Scientists use herpes virus and common cold to fight brain tumors
According to data from the Statista platform, the market for medical technology It will continue to grow in the face of 2022 to mark the future of medicine. According to the World Intellectual Property Organization (WIPO), medical innovation promises new ways of prevent, diagnose and monitor health problems. Likewise, it proposes the development of new drugs and devices to address the treatment of diseases and illnesses in order to improve the scope of medicine.
In this sense, one of the world leaders in terms of medical innovation is the Houston Methodist Hospitalwhose team shared with NotiPress three projects that will mark the future of medicine hand in hand with innovation. Between these medical innovations highlight liver transplant for patients with this type of cancer, the development of nanotechnology, as well as clinical trials to combat brain tumors.
This medical innovation was born from a study conducted at the Houston Methodist, JC Walter Jr. Transplant Center and the MD Anderson Cancer Centerof the University of Texas. Twelve patients with liver cancer were studied, of whom six received liver transplants. In this group, the survival rate was 100% at one year and 83% at five years.
Also, 50% of patients had no cancer recurrence more than five years after transplantation. “These results are promising, because at this time there is no cure for liver cancer if the tumor cannot be surgically removed,” commented the doctor R. Mark Ghobrialhead of Liver Transplantation at the Hospital Transplant Center.
Scientists headed by doctor Alessandro Grattonipresident of the Department of Nanomedicine began to apply nanotechnology in chronic-degenerative ailments such as arthritis, diabetes, or heart disease.This nanodevice is the size of a grape and is remotely controlled, gradually releasing the medicine that each patient needs.
In this context, the implant goes under the skin and can accommodate up to a full year’s worth of medications before needing to be refilled. “With this research we see this universal drug implantation as the future of care for chronic diseases, because it does not have the drawback of oral doses, which are frequently forgotten by patients, nor night doses, which are often skipped” , explained the principal investigator of the study and creator of the device, Dr. Grattoni.
Another medical innovation in which the Houston Methodist Hospital participated is the study that proposes the use of the herpes virus and the common cold to combat brain tumors. As part of these clinical trials, inactivated herpes virus DNA is combined with the common cold virus and injected into the brain tissue surrounding the area where the core of the tumor is.
“We chose the common cold virus because of its ability to spread rapidly and reach many of the hard-to-reach tumor cells and spread through remaining tumor branches that cannot be removed with surgery.”. explained the doctor David Baskinneurosurgeon and director of the Center for Brain and Pituitary Tumors at Houston Methodist Hospital.
As the WIPO suggests, medical innovation will be the factor that will mark the future of medicine in the not too distant future. Under this line, medicine must innovate in technological and academic matters in order to achieve the desired results, that is, to provide a cure and well-being to the entire population in general.